Michael Scolaro

Michael Scolaro

Nov 16, 2017

Group 6 Copy 196
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    The Effects of Sudarshan Kriya Yoga (SKY) in patients with Post Traumatic Stress Disorder (PTSD)

    Sudarshan Kriya Yoga (SKY) is a standardized series of breathing techniques that has beneficial effects...

    Dicty World Race - finding the fastest and smartest Dicty cells

    On May 16, Dicty and HL60 cells will race for the "fastest &smartest" title. Both cell types are models...

    Saving lives with synthetic antivenoms: looking for novel solutions to Lonomia envenoming in Colombia

    Venomous caterpillars of the genus Lonomia cause deadly accidents in Colombia. In Brazil it is estimated...

    Backer Badge Funded